Page last updated: 2024-08-24

triptonide and Acute Myelogenous Leukemia

triptonide has been researched along with Acute Myelogenous Leukemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Li, M; Li, X; Shen, J; Wang, P; Wu, Z; Xu, R; Xu, Y1

Other Studies

1 other study(ies) available for triptonide and Acute Myelogenous Leukemia

ArticleYear
Natural small molecule triptonide inhibits lethal acute myeloid leukemia with FLT3-ITD mutation by targeting Hedgehog/FLT3 signaling.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 133

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Female; fms-Like Tyrosine Kinase 3; Gene Expression Regulation, Neoplastic; Hedgehog Proteins; Humans; Leukemia, Myeloid, Acute; Mice, Inbred NOD; Mice, SCID; Nuclear Proteins; Proto-Oncogene Proteins c-myc; Signal Transduction; Tandem Repeat Sequences; Triterpenes; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays; Zinc Finger Protein Gli2

2021
chemdatabank.com